Sarcopenia and frailty as predictors of surgical morbidity and oncologic outcomes in retroperitoneal sarcoma.
Aida NasirisharghMonica GrovaCyrus P BateniSean J JudgeMiriam A NunoUgur Nur BasmaciRobert J CanterSarah B BateniPublished in: Journal of surgical oncology (2023)
This study suggests that sarcopenia may be utilized as a measure of overall fitness, rather than a cancer-specific risk, and the mFI is a poor predictive measure of outcomes in RPS.